0001501134-20-000083.txt : 20201120 0001501134-20-000083.hdr.sgml : 20201120 20201120211355 ACCESSION NUMBER: 0001501134-20-000083 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201118 FILED AS OF DATE: 20201120 DATE AS OF CHANGE: 20201120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Guyer Shelly D CENTRAL INDEX KEY: 0001588984 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36847 FILM NUMBER: 201334114 MAIL ADDRESS: STREET 1: 1025 GREEN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94133 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Invitae Corp CENTRAL INDEX KEY: 0001501134 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 271701898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1400 16TH STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 374-7782 MAIL ADDRESS: STREET 1: 1400 16TH STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: InVitae Corp DATE OF NAME CHANGE: 20121105 FORMER COMPANY: FORMER CONFORMED NAME: Locus Development Inc DATE OF NAME CHANGE: 20100910 4 1 wf-form4_160592482126942.xml FORM 4 X0306 4 2020-11-18 0 0001501134 Invitae Corp NVTA 0001588984 Guyer Shelly D C/O INVITAE CORPORATION 1400 16TH STREET SAN FRANCISCO CA 94103 0 1 0 0 Chief Financial Officer Common Stock 2020-11-18 4 S 0 1513 46.20 D 226007 D Common Stock 2020-11-18 4 S 0 1187 47.17 D 224820 D Common Stock 2020-11-18 4 S 0 300 47.91 D 224520 D The sales of common stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2020. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.69 to $46.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Includes an aggregate of 161,973 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.73 to $47.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.80 to $48.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. /s/ Thomas Brida, Attorney-in-fact 2020-11-20